Elena D Serban & Mihai Manolache; Journal of Comparative Effectiveness ResearchVol. 8, No. 3
Publication of a retrospective, observational study on Gelatin tannate versus other antidiarrheal medication in children with acute gastroenteritis.
Aim: To evaluate the effectiveness and safety of gelatin tannate (GT) for acute gastroenteritis (AGE) in children.
Conclusion: This study adds to the evidence that GT, alone or in combination with ORS, can alleviate AGE-associated symptoms in children more effectively and more efficiently (quicker) than conventional treatment.
GT is marketed under the brand name Tasectan®
Tasectan® is a class III medical device and complies with the Essential Requirements of Directive 93/42/EEC and subsequent amendments (CE 0373, Noventure SL).
In accordance with article 5 of the Spanish Law RDL1/2015, the information set out in the following sections is intended for healthcare professionals.
Access to this information and all use which may be made thereof or of these contents is exclusive responsibility of those who use them. Noventure will not be held liable for any illegal or improper use or for the manipulation of the contents and information included in these pages.